UBS AM’s Aveanna Healthcare AVAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$831K Buy
96,956
+14,492
+18% +$102K ﹤0.01% 2398
2026
Q1
$531K Buy
82,464
+11,210
+16% +$86.7K ﹤0.01% 2540
2025
Q4
$582K Buy
71,254
+21,904
+44% +$198K ﹤0.01% 2293
2025
Q3
$438K Sell
49,350
-48,513
-50% -$307K ﹤0.01% 2173
2025
Q2
$512K Buy
97,863
+49,082
+101% +$250K ﹤0.01% 2483
2025
Q1
$264K Hold
48,781
﹤0.01% 2564
2024
Q4
$223K Buy
+48,781
New +$250K ﹤0.01% 2632
2022
Q4
Sell
-21,000
Closed -$31.5K 2575
2022
Q3
$31.5K Hold
21,000
﹤0.01% 2723
2022
Q2
$47.5K Hold
21,000
﹤0.01% 2672
2022
Q1
$71.6K Hold
21,000
﹤0.01% 2753
2021
Q4
$155K Buy
+21,000
New +$153K ﹤0.01% 2790

Other funds holding AVAH

UBS AM's AVAH Position: Q2 2026 in Review

UBS AM increased its Aveanna Healthcare (AVAH) stake by 18% in Q2 2026, buying an estimated $102K and bringing the position to 96,956 shares worth $831K. The position accounts for ﹤0.01% of the portfolio, ranked #2398.

UBS AM first reported a position in AVAH in Q4 2021 and has held it in 11 quarters since. 215 funds tracked by Wall St. Rank hold AVAH as of Q2 2026.

  • UBS AM held 96,956 shares of Aveanna Healthcare worth $831K as of Q2 2026.
  • UBS AM bought 14,492 Aveanna Healthcare shares in Q2 2026, an estimated $102K.
  • Aveanna Healthcare made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #2398 holding.
  • UBS AM first reported a position in Aveanna Healthcare in Q4 2021 and has held it in 11 quarters since.
  • 215 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.